| Financial Year |
March 31 2023 |
| Monetary Funds |
1,340,387,873.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,686,195.80 |
| Accounts Receivable |
2,214,966,355.03 |
| Advances to Suppliers |
672,714,240.23 |
| Other Receivables |
120,215,616.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,067,915,039.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
287,593,828.66 |
| Total Current Assets |
6,850,082,433.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
277,237,683.11 |
| Investment Properties |
445,093,909.12 |
| Fixed Assetes |
1,570,645,057.79 |
| Under-construction Projects |
227,938,878.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
311,090,357.04 |
| R&D expenses |
139,103,838.51 |
| Goodwill |
255,925,511.51 |
| Long-Term Deferred and Prepaid Expenses |
46,517,522.56 |
| Deferred Income Tax Assets |
119,642,717.28 |
| Other Non-Current Assets |
120,688,548.71 |
| Sub-Total of Non-Current Assets |
3,927,426,510.63 |
| Total Assets |
10,777,508,944.49 |
| Short-Term Loans |
2,248,486,238.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
565,000.00 |
| Accounts Payable |
1,213,468,546.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,625,849.23 |
| Taxes Payable |
126,270,213.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
260,459,658.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
321,974,903.98 |
| Other Current Liabilities |
106,680,639.90 |
| Sub-Total of Current Liabilities |
4,607,595,648.15 |
| Long-term Loans |
959,348,281.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
166,600,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
66,778,752.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,384,766,092.30 |
| Total Liabilities |
5,992,361,740.45 |
| Paid-In Capital(Or Share Stock) |
321,661,174.00 |
| Capital Surplus |
3,121,840,994.32 |
| Surplus Reserve |
81,528,035.49 |
| LESS:Treasury Stock |
80,199,097.60 |
| Undistributed Profits |
1,010,931,722.29 |
| Minority Stockholder's Interest |
247,042,437.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,538,104,766.38 |
| Owner's Equity（Stockholder's Equity） |
4,785,147,204.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,777,508,944.49 |
